193 related articles for article (PubMed ID: 28604257)
1. Genetic factors related with early onset of osteonecrosis of the jaw in patients with multiple myeloma under zoledronic acid therapy.
Kastritis E; Melea P; Bagratuni T; Melakopoulos I; Gavriatopoulou M; Roussou M; Migkou M; Eleutherakis-Papaiakovou E; Terpos E; Dimopoulos MA
Leuk Lymphoma; 2017 Oct; 58(10):2304-2309. PubMed ID: 28604257
[TBL] [Abstract][Full Text] [Related]
2. CYP2C8 gene polymorphism and bisphosphonate-related osteonecrosis of the jaw in patients with multiple myeloma.
Such E; Cervera J; Terpos E; Bagán JV; Avaria A; Gómez I; Margaix M; Ibañez M; Luna I; Cordón L; Roig M; Sanz MA; Dimopoulos MA; de la Rubia J
Haematologica; 2011 Oct; 96(10):1557-9. PubMed ID: 21685474
[TBL] [Abstract][Full Text] [Related]
3. A peroxisome proliferator-activated receptor gamma (PPARG) polymorphism is associated with zoledronic acid-related osteonecrosis of the jaw in multiple myeloma patients: analysis by DMET microarray profiling.
Di Martino MT; Arbitrio M; Guzzi PH; Leone E; Baudi F; Piro E; Prantera T; Cucinotto I; Calimeri T; Rossi M; Veltri P; Cannataro M; Tagliaferri P; Tassone P
Br J Haematol; 2011 Aug; 154(4):529-33. PubMed ID: 21517810
[No Abstract] [Full Text] [Related]
4. Preventive dental management of osteonecrosis of the jaws related to zoledronic acid treatment.
Coello-Suanzes JA; Rollon-Ugalde V; Castaño-Seiquer A; Lledo-Villar E; Herce-Lopez J; Infante-Cossio P; Rollon-Mayordomo A
Oral Dis; 2018 Sep; 24(6):1029-1036. PubMed ID: 29412504
[TBL] [Abstract][Full Text] [Related]
5. Bisphosphonate-related osteonecrosis: genetic and acquired risk factors.
Sarasquete ME; González M; San Miguel JF; García-Sanz R
Oral Dis; 2009 Sep; 15(6):382-7. PubMed ID: 19413677
[TBL] [Abstract][Full Text] [Related]
6. Role of intravenous dosage regimens of bisphosphonates in relation to other aetiological factors in the development of osteonecrosis of the jaws in patients with myeloma.
Jarnbring F; Kashani A; Björk A; Hoffman T; Krawiec K; Ljungman P; Lund B
Br J Oral Maxillofac Surg; 2015 Dec; 53(10):1007-11. PubMed ID: 26530732
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of bisphosphonate-related osteonecrosis of the jaw-like lesions is increased in a chemotherapeutic dose-dependent manner in mice.
Kuroshima S; Sasaki M; Nakajima K; Tamaki S; Hayano H; Sawase T
Bone; 2018 Jul; 112():177-186. PubMed ID: 29729428
[TBL] [Abstract][Full Text] [Related]
8. Bisphosphonate-related osteonecrosis of the jaws--a case report.
Kamoh AK; Ogle O
Compend Contin Educ Dent; 2012 May; 33(5):e74-7. PubMed ID: 23268588
[TBL] [Abstract][Full Text] [Related]
9. Association between CYP2C8 (rs1934951) polymorphism and bisphosphonate-related osteonecrosis of the jaws in patients on bisphosphonate therapy: a meta-analysis.
Zhong DN; Wu JZ; Li GJ
Acta Haematol; 2013; 129(2):90-5. PubMed ID: 23171856
[TBL] [Abstract][Full Text] [Related]
10. Intravenous bisphosphonate-related osteonecrosis of the jaw: bone scintigraphy as an early indicator.
O'Ryan FS; Khoury S; Liao W; Han MM; Hui RL; Baer D; Martin D; Liberty D; Lo JC
J Oral Maxillofac Surg; 2009 Jul; 67(7):1363-72. PubMed ID: 19531404
[TBL] [Abstract][Full Text] [Related]
11. Bisphosphonate-related osteonecrosis of the jaw is associated with polymorphisms of the cytochrome P450 CYP2C8 in multiple myeloma: a genome-wide single nucleotide polymorphism analysis.
Sarasquete ME; García-Sanz R; Marín L; Alcoceba M; Chillón MC; Balanzategui A; Santamaria C; Rosiñol L; de la Rubia J; Hernandez MT; Garcia-Navarro I; Lahuerta JJ; González M; San Miguel JF
Blood; 2008 Oct; 112(7):2709-12. PubMed ID: 18594024
[TBL] [Abstract][Full Text] [Related]
12. Zoledronic acid promotes TLR-4-mediated M1 macrophage polarization in bisphosphonate-related osteonecrosis of the jaw.
Zhu W; Xu R; Du J; Fu Y; Li S; Zhang P; Liu L; Jiang H
FASEB J; 2019 Apr; 33(4):5208-5219. PubMed ID: 30624969
[TBL] [Abstract][Full Text] [Related]
13. Is oral bisphosphonate-related osteonecrosis of the jaw an endemic condition?
Diz P; Limeres J; Fedele S; Seoane J; Diniz M; Feijoo JF
Med Hypotheses; 2012 Feb; 78(2):315-8. PubMed ID: 22136947
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of a method using ultra performance liquid chromatography coupled to tandem mass spectrometry for determination of zoledronic acid concentration in human bone.
Lo Faro AF; Giorgetti R; Busardò FP; Lodi G; Martini V; Pispero A; Iriti M; Varoni EM
J Pharm Biomed Anal; 2019 Jan; 162():286-290. PubMed ID: 30273818
[TBL] [Abstract][Full Text] [Related]
15. Effects of dexamethasone and nimesulide on bisphosphonate-related osteonecrosis of the jaw: An experimental study.
Oliveira CC; Barros Silva PG; Ferreira AEC; Gonçalves RP; Sousa FB; Mota MRL; Alves APNN
Arch Oral Biol; 2017 Nov; 83():317-326. PubMed ID: 28869827
[TBL] [Abstract][Full Text] [Related]
16. Prevention of bisphosphonate-related osteonecrosis of the jaws in patients with prostate cancer treated with zoledronic acid - A prospective study over 6 years.
Mücke T; Deppe H; Hein J; Wolff KD; Mitchell DA; Kesting MR; Retz M; Gschwend JE; Thalgott M
J Craniomaxillofac Surg; 2016 Oct; 44(10):1689-1693. PubMed ID: 27555374
[TBL] [Abstract][Full Text] [Related]
17. Denosumab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: an international, double-blind, double-dummy, randomised, controlled, phase 3 study.
Raje N; Terpos E; Willenbacher W; Shimizu K; García-Sanz R; Durie B; Legieć W; Krejčí M; Laribi K; Zhu L; Cheng P; Warner D; Roodman GD
Lancet Oncol; 2018 Mar; 19(3):370-381. PubMed ID: 29429912
[TBL] [Abstract][Full Text] [Related]
18. Bisphosphonate-related osteonecrosis of the jaw: from the sine qua non condition of bone exposure to a non-exposed BRONJ entity.
Koth VS; Figueiredo MA; Salum FG; Cherubini K
Dentomaxillofac Radiol; 2016; 45(7):20160049. PubMed ID: 27167455
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of the early stages of intravenous bisphosphonate-related osteonecrosis of the jaw in patients with breast cancer.
Matsuo A; Hamada H; Kaise H; Chikazu D; Yamada K; Kohno N
Acta Odontol Scand; 2014 Nov; 72(8):656-63. PubMed ID: 24521290
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor genetic polymorphisms and haplotypes in female patients with bisphosphonate-related osteonecrosis of the jaws.
Arduino PG; Menegatti E; Scoletta M; Battaglio C; Mozzati M; Chiecchio A; Berardi D; Vandone AM; Donadio M; Gandolfo S; Scully C; Broccoletti R
J Oral Pathol Med; 2011 Jul; 40(6):510-5. PubMed ID: 21251073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
